The Vaccine Study Center joins the clinical trial for Pfizer/BioNTech’s COVID-19 vaccine, enrolling adults and later teenagers aged 16 and 17, adolescents aged 12 to 15, and children aged 6 to 11.
The Vaccine Study Center joins the clinical trial for Pfizer/BioNTech’s COVID-19 vaccine, enrolling adults and later teenagers aged 16 and 17, adolescents aged 12 to 15, and children aged 6 to 11.